A library of recent articles, news and insights.


07/16/2021Press Release

Visby Medical Makes Strategic Hires to Continue Business Development

Visby Medical appoints Mark Ibison as Chief Financial Officer, Christopher J. Jowett as Chief Commercial Officer, and Alicia Zuiker as Chief People Officer

Read More


COVID-19 Testing: Its Role in Safely Reopening

The global COVID-19 pandemic touches and disrupts every aspect of life and livelihood across geographies. Despite progress with public health practices and vaccinations, our personal and professional futures face uncertainty. Inconsistent and ambiguous re-opening procedures hinder a robust return to pre-pandemic routines that can restore productivity and economic health.

Read More

04/22/2021Rapid Testing

Will COVID Testing Be Needed When the Pandemic Ends?

With the COVID-19 vaccine being distributed and overall infection rates stabilizing, people are beginning to talk about life after the pandemic. Anxious to get back to some kind of normality, even if it means adopting a new normal that includes continued mask wearing and physical distancing, businesses are making plans to open back up.

Read More

02/02/2021Press Release

Visby Medical’s COVID-19 PCR Point of Care Test Authorized for Use in CLIA Waived Settings

Expanding critical access to the only single-use, rapid PCR test, at the point of care.

Read More

02/02/2021Press Release

Visby Medical speeds development of a rapid Flu-COVID PCR test designed for at-home use with BARDA funding

Visby Medical pairs speed with the accuracy of gold-standard PCR testing in a single-use device, so doctors don’t have to fight blind.

Read More


Lancet publishes paper on the Visby Medical point-of-care PCR technology

A study of the performance of the Visby Medical Sexual Health Test, a single-use, point-of-care PCR device.

Read More


What is PCR?

PCR’s superpower lies in its super sensitivity, which enables it to sniff out even low levels of a pathogen in minutes. Here’s how it works.

Read More

10/06/2020Press Release

Visby Medical’s Personal PCR Receives Funding from National Institute of Health, RADx Program

Visby Medical, an infectious disease diagnostic company, received funding from the National Institutes of Health as part of the organization’s Rapid Acceleration of Diagnostics (RADx) program, an initiative that aims to combat SARS-CoV-2 and increase national testing capacity for COVID-19.

Read More


Personal PCR: Rapid, Reliable, and Prolific

Personal PCR could one day become as common as the common cold. In the future, the device will deliver lab accurate results anywhere and to anyone — forever changing our relationship with diagnostics.

Read More

09/16/2020Press Release

Visby Medical’s Personal PCR Device Receives FDA Emergency Use Authorization for Moderate-Complexity Lab Environments

Seven-year-old startup emerges from stealth mode, provides adaptable and rapid testing technology to frontline lab personnel fighting the pandemic

Read More


Visby exits stealth to bring its Personal PCR Test to the fight against COVID-19

Now that Visby has received EUA for our Personal PCR Test to be deployed in moderate-complexity CLIA-certified labs, we’re taking it to the front line of the fight against COVID-19. Each device is personal to individual patients, with results delivered to a lab technician in less than 30 minutes.

Read More

08/05/2020Press Release

Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistance

As appeared in NIH website 8/5/20

Read More

Our Press Kit

Get the assets you need to talk about Visby here.